Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02094781
Other study ID # 200616
Secondary ID RH01717
Status Completed
Phase Phase 1
First received February 27, 2014
Last updated December 11, 2014
Start date December 2013
Est. completion date September 2014

Study information

Verified date December 2014
Source GlaxoSmithKline
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The purpose of this study was to evaluate the effect of combined whey protein and creatine supplement, as compared with whey protein supplement alone, on change in upper and lower body strength.


Recruitment information / eligibility

Status Completed
Enrollment 18
Est. completion date September 2014
Est. primary completion date September 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria:

- Recreationally active males

- Age 18 to 35 years

- BMI 19 to 29.9 kg/m2

- Weight training 3 to 4 times a week for at least 6 months before the trial

Exclusion Criteria:

- Participants with medical conditions including active heart disease, high blood pressure, renal or hepatic impairment type I or II diabetes, bipolar disease, pulmonary disease, thyroid disease, immune disorder, psychiatric disorder

- Dietary or herbal supplement used in the past 60 days to increase muscle mass

- Use of protein supplement in the past 7 days

- Use of thermogenic supplement or beverage in the past 7 days

- Use of Non-steroidal anti inflammatory drugs or corticosteroids in the past 7 days

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Basic Science


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Whey protein and creatine supplement
Each sachet contained 30g whey protein powder and 5g creatine powder, administered twice a day. The first serving was consumed with breakfast and the second serving was consumed within 60 minutes of completing training or in the evening on non-training days. Participants also drank at least 2 litres of water per day
Whey protein only supplement
Each sachet contained 30g of whey protein powder and 5g of bulking agent powder, administered twice a day. The first serving was consumed with breakfast and the second serving was consumed within 60 minutes of completing training or in the evening on non-training days. Participants also drank at least 2 litres of water per day
Placebo
Each sachet contained 30g of isocaloric carbohydrate powder and 5g of bulking agent powder, administered twice a day. The first serving was consumed with breakfast and the second serving was consumed within 60 minutes of completing training or in the evening on non-training days. Participants also drank at least 2 litres of water per day

Locations

Country Name City State
United States GSK Investigational Site Miami Florida

Sponsors (1)

Lead Sponsor Collaborator
GlaxoSmithKline

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary To evaluate the effect of combined whey protein and creatine supplement, as compared with whey protein supplement alone, on change in upper body strength from Baseline to Week 4. Body strength will be evaluated using Repetition maximum (1-RM) and bench and leg press exercise testing. 1-RM in weight training is the maximum amount of weight one can lift in a single repetition for a given exercise Baseline, Week 2, 4, 8 and 12 No
Secondary To evaluate the effect of combined whey protein and creatine supplement, as compared with whey protein supplement alone, on changes in upper and lower body strength from Baseline through Week 12 Body strength will be evaluated using 1-RM and bench and leg press exercise testing Baseline, Week 2, 4, 8 and 12 No
Secondary To evaluate the effect of combined whey protein and creatine supplement, as compared with placebo, on changes in upper and lower body strength from Baseline through Week 12. Body strength will be evaluated using 1-RM and bench and leg press exercise testing Baseline, Week 2, 4, 8 and 12 No
Secondary To compare changes in upper and lower body strength from Baseline through Week 12, between combined whey protein and creatine supplement, whey protein supplement alone, and placebo. Body strength will be evaluated using 1-RM and bench and leg press exercise testing Baseline, Week 2, 4, 8 and 12 No
Secondary To compare changes in upper and lower body endurance from Baseline through Week 12, between combined whey protein and creatine supplement, whey protein supplement alone, and placebo. Body endurance will be measured using bench press and leg press exercise testing Baseline, Week 2, 4, 8 and 12 No
Secondary To compare the changes in lean vs. fat body mass composition from Baseline to Week 12 between combined whey protein and creatine supplement, whey protein supplement alone, and placebo. Body composition [(fat-free mass and fat mass (grams and % body fat, bone mass)] will be calculated using Dual X-Ray Absorptiometry (DXA) Baseline and Week 12 No
See also
  Status Clinical Trial Phase
Recruiting NCT04656327 - Oral Health Status in Care-dependent Community Dwelling Elders
Completed NCT01214785 - Cluster Randomised Trial of Improved Sanitation in Rural Orissa, India N/A
Recruiting NCT06351007 - Educational Program on Dietary Adherence and Nutritional Knowledge in Chronic Kidney Disease Patients (EPAK) N/A
Recruiting NCT03286348 - Analysis of Nutrition During Chemoradiotherapy in Patients With Gastrointestinal Cancer N/A
Terminated NCT04413604 - Micronutrient Status in Children Aged 1-3 Years Consuming Their Habitual Diet With or Without Young Children's Milk N/A
Completed NCT02583880 - Screening Day Latin America N/A
Completed NCT03941392 - Nutritional Study in Spanish Pediatric Population
Completed NCT05867810 - Nutritional Status Among Upper Gastrointestinal Cancer Patients Upon Admission
Completed NCT04921085 - Nutritional Status Study of Inpatients in Hospitals
Completed NCT02201225 - A Methodology Study to Evaluate a Sitting Knee Measuring Device in Assessing Growth in Indian Children. Phase 1
Completed NCT02589704 - Nutritional Status of Cerebral Palsy Patients in Turkey N/A
Completed NCT05144919 - Biodiversity in the Diet in Vietnam N/A
Completed NCT02592109 - Effect of Enhanced Counseling Using Complementary Feeding Recommendation Based on Linear Programming on Nutritional Status,Omega-3 Fatty Acids, Malondialdehyde, and Alpha-Tocopherol in Overweight Children in East Jakarta Phase 2
Completed NCT04204538 - Dietary Practices and Metabolic Syndrome in the Young Adult Population of Rwanda
Recruiting NCT03759548 - Nutritional Status and Pharmacological Treatment: Impact on the Toxicity and Quality of Life of Patients With Colorectal and Breast Cancer
Recruiting NCT03915158 - Nutritional Status of Patients Before and After Bariatric Surgery
Completed NCT03488680 - Effectiveness of Behavior Change Communication in Improving Feeding Practices, Nutritional and Health Status of Infants N/A
Active, not recruiting NCT04431076 - Patient Reported Outcomes Measures to Predict Pancreatic Surgery Outcomes
Enrolling by invitation NCT05389618 - Dietary Challenges in the Population of Nursing Homes' Residents
Completed NCT01492946 - Impaired Preoperative Nutritional Status as a Risk Factor for Postoperative Clinical Outcome N/A